Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 30, 2017

View Archived Issues

Celgene offers product and pipeline update for third quarter 2017

Bristol-Myers Squibb offers product and pipeline update from third quarter 2017

Mitobridge describes novel PPAR-delta agonists

JCR Pharmaceuticals to initiate development of JR-171 for Hurler Syndrome

Allergan presents new fMet-Leu-Phe receptor modulators

Boehringer Ingelheim discovers new orexin receptor type 1 antagonists

Novel proto-oncogene c-Ret inhibitors identified at Cancer Research Technology

DS-5010 demonstrates potent antitumor activity in vitro and in vivo

New antibacterials patented by Actelion Pharmaceuticals

FDA grants priority review to elagolix for endometriosis-associated pain

Successful tumor imagining with novel somatostatin receptor antagonist 68Ga-NODAGA-LM3

Fostemsavir reduces HIV-1 viral load in heavily treatment-experienced patients

Phase I trial to evaluate Curevac's immunomodulator CV-8102

Sumitomo Dainippon and Poxel sign strategic partnership for imeglimin in Asias countries

Merck & Co. withdraws European application for Keytruda in first-line metastatic non-squamous NSCLC

Novartis proposes to acquire Advanced Accelerator Applications

Argenx initiates phase I trial of subcutaneous formulation of ARGX-113

Clinical data for maralixibat in patients with Alagille syndrome presented

Janssen conducts phase 0 exploratory trial of [18F]MNI-1020 as imaging marker for tau protein

Reversible 18F-labeled tracer GEH200431-B a potential candidate for MAO-B imaging in humans

Rgenix releases preliminary phase Ia/b data on RGX-104 in advanced cancer

[Ga68]PSMA bimodal probe for radio- and fluorescence-guided surgery of prostate cancer

Longevity Biotech awarded grant to evaluate LBT-3627 for multiple sclerosis

New phase I study at Stanford explores CD19/CD22-CAR T cells for B-cell malignancies

Mereo agrees with AstraZeneca on exclusive license and option to acquire AZD-9668

New ATOM consortium aims to reduce preclinical cancer drug discovery time

Astellas establishes screening collaboration agreement with MMV for malaria

Daiichi Sankyo and Glycotope sign option agreement on ADC collaboration and licensing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...